Efficacy of Home-Based Posture Exercises as an Addition to Pharmacological Treatment in Fibromyalgia
1 other identifier
interventional
55
1 country
1
Brief Summary
This interventional study aimed to evaluate the effects of home exercise in addition to pharmacological treatment on pain threshold and spinal mobility in fibromyalgia patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2024
CompletedFirst Posted
Study publicly available on registry
December 17, 2024
CompletedStudy Start
First participant enrolled
January 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2025
CompletedJanuary 22, 2026
January 1, 2026
11 months
December 13, 2024
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Algometry
pain pressure threshold
4 weeks
Spinal mouse for spinal mobility
spinal range of motion
4 weeks
Secondary Outcomes (3)
Hospital Anxiety and Depression Scale (HADS)
4 weeks
Pittsburgh Sleep Quality Index (PSQI)
4 weeks
Short form-12 (SF-12)
4 weeks
Study Arms (2)
Duloxetin+home based therapy
EXPERIMENTALParticipants in this arm will receive standard pharmacological treatment for fibromyalgia as prescribed by a physician, in addition to a structured home exercise program. The home exercise program will include stretching and strengthening exercises targeting the spinal and trunk muscles and will be performed according to the study protocol. Clinical outcomes and spinal posture and mobility will be assessed using the Spinal Mouse® device in upright standing, maximum trunk flexion, and maximum trunk extension positions at baseline and follow-up.
Duloxetin only
NO INTERVENTIONParticipants in this arm will receive standard pharmacological treatment for fibromyalgia as prescribed by a physician, without any additional exercise intervention. Clinical outcomes and spinal posture and mobility will be assessed using the Spinal Mouse® device in upright standing, maximum trunk flexion, and maximum trunk extension positions at baseline and follow-up.
Interventions
Eligibility Criteria
You may qualify if:
- Participants were between the ages of 18 and 65,
- No diagnosis of rheumatic disease,
- No diagnosis of chronic comorbid disease,
- Participants diagnosed with fibromyalgia syndrome according to the European League Against Rheumatism (EULAR) criteria will be included as volunteers.
You may not qualify if:
- Patients under 18, over 65 years of age
- Those diagnosed with chronic comorbid diseases
- Those with a history of rheumatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahi Evran University
Kırşehir, Turkey (Türkiye)
Related Publications (1)
Ozcelep OF, Ustun I, Algun ZC. Effect of task-oriented training on pain, functionality, and quality of life in rheumatoid arthritis. Turk J Phys Med Rehabil. 2022 Mar 1;68(1):76-83. doi: 10.5606/tftrd.2022.6666. eCollection 2022 Mar.
PMID: 35949976RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
December 13, 2024
First Posted
December 17, 2024
Study Start
January 25, 2025
Primary Completion
December 25, 2025
Study Completion
December 28, 2025
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share